ALGN vs CTMX · P/E 35, rev $2.10B vs rev $11.7M
Align Technology Inc (ALGN) versus CytomX Therapeutics Inc (CTMX) — a side-by-side from cached financials, not a winner call.
Align Technology Inc (ALGN) is a medical instruments & supplies company listed on US.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Latest reported ALGN revenue for 2026-06-30 was $2.10B. Net income was $221.1M. ALGN currently screens at market cap $14.17B and trailing P/E 35.2.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
ALGN currently screens at market cap $14.17B and trailing P/E 35.2. CTMX currently screens at market cap $653.1M.
Not investment advice. Open the ALGN and CTMX stock pages for the full models.
Not investment advice.